Li Zhou
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 8
- Acute Kidney Injury Research 7
- Biochemistry top 5%
- Molecular Biology top 5%
- Cell death mechanisms and regulation 7
- Inflammasome and immune disorders 7
- Cancer Research top 10%
-
- Osteoarthritis Treatment and Mechanisms 14
-
- Mesenchymal stem cell research 8
-
- Periodontal Regeneration and Treatments 7
-
- Renin-Angiotensin System Studies 6
- Journals
- Acta Pharmacologica Sinica (15 papers)Frontiers in Pharmacology (8 papers)Drug Design Development and Therapy (4 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Li Zhou
113 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 122
- Nephrology 360
- Biochemistry 146
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 306
- Cancer Research 246
Countries citing papers authored by Li Zhou
This map shows the geographic impact of Li Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhou more than expected).
Fields of papers citing papers by Li Zhou
This network shows the impact of papers produced by Li Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhou. The network helps show where Li Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 50 | |
| 8 | 2021 | 32 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 12 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 15 | |
| 13 | 2019 | 182 | |
| 14 | 2017 | 51 | |
| 15 | 2017 | 19 | |
| 16 | 2016 | 2 | |
| 17 | 2014 | 30 | |
| 18 | 2013 | 14 | |
| 19 | 1995 | 22 | |
| 20 | [Changes of endogenous opioid peptides content in RPGL during acupuncture analgesia]. | 1993 | 3 |
About Li Zhou
Li Zhou is a scholar working on Nephrology, Applied Microbiology and Biotechnology, Urology, Rheumatology and Complementary and alternative medicine, having authored 119 papers that have together received 2.7k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (14 papers), Chronic Kidney Disease and Diabetes (8 papers), Mesenchymal stem cell research (8 papers), Acute Kidney Injury Research (7 papers), Cell death mechanisms and regulation (7 papers), Inflammasome and immune disorders (7 papers), Periodontal Regeneration and Treatments (7 papers) and Renin-Angiotensin System Studies (6 papers). The work is most often cited by research in Nephrology (360 citations), Biochemistry (146 citations), Molecular Biology (1.3k citations), Pathology and Forensic Medicine (306 citations) and Cancer Research (246 citations). Li Zhou has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Limin Lü, Hong Xue, Letian Shan, Yang Shen, Hongyan Xie, Naijun Miao, Yü Huang, Jun Ni, Zhuanli Zhou and Qian Cheng. Their work appears in journals such as Acta Pharmacologica Sinica, Frontiers in Pharmacology, Drug Design Development and Therapy, OncoTargets and Therapy and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.